Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer
Katharina Böehm(Vrije Universiteit Amsterdam), Derya Tilki(Koç University), Markus Graefen(Eppendorf (Germany)), Alessandro Larcher(IRCCS Ospedale San Raffaele), Andreas Krüll(Universität Hamburg), Hans Lesmana(Universität Hamburg), Pierre I. Karakiewicz(Université de Montréal), Philipp Mandel(Universität Hamburg), Zhe Tian(Tianjin University), Rudolf Schwarz(Universität Hamburg), Jonas Schiffmann(Universität Hamburg)
Cited by 15
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
|Journal of Clinical Oncology|2005|347
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|344